Evidence map›Paper›PMID 33738459›Full record

ArticleBiomarkers in neuropsychiatry2020

Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.

K Juston Osborne, Sebastian Walther, Stewart A Shankman, Vijay A Mittal

Abstract read
In one paragraph

Article in Biomarkers in neuropsychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Impaired effort allocation in schizophrenia.Schizophrenia research. Cognition · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Motor precision deficits in clinical high risk for psychosis.European archives of psychiatry and clinical neuroscience · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

K Juston OsborneNorthwestern University, Department of Psychology, Evanston, IL, USA.
Sebastian WaltherUniversity of Bern, University Hospital of Psychiatry, Translational Research Center, Bern, Switzerland.
Stewart A ShankmanNorthwestern University, Department of Psychology, Evanston, IL, USA.
Vijay A MittalNorthwestern University, Department of Psychology, Evanston, IL, USA.

Funding

TRAINING PROGRAM IN THE NEUROSCIENCE OF HUMAN COGNITIONT32NS047987 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Rodrigo M Braga, Christina Maria Zelano · 2006 to 2026
$5.6M
An examination of psychomotor disturbance in current and remitted MDD: An RDoC StudyR01MH118741 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MITTAL, VIJAY A, SHANKMAN, STEWART AARON · 2019 to 2023
$3.4M
Frontal-Subcortical Development, Movement Abnormalities, and Risk for PsychosisR01MH094650 · NIMH · UNIVERSITY OF COLORADO · PI MITTAL, VIJAY A · 2011 to 2015
$2.3M
Exercise and markers of medial temporal health in youth at-risk for psychosisR33MH103231 · NIMH · NORTHWESTERN UNIVERSITY · PI BRYAN, ANGELA, MITTAL, VIJAY A · 2016 to 2018
$689k
Exercise and markers of medial temporal health in youth at-risk for psychosisR21MH103231 · NIMH · UNIVERSITY OF COLORADO · PI BRYAN, ANGELA, MITTAL, VIJAY A · 2014 to 2015
$489k
Using Speech Acoustics to Reveal Motor Disruptions in PsychosisR21MH119677 · NIMH · NORTHWESTERN UNIVERSITY · PI GOLDRICK, MATTHEW A, MITTAL, VIJAY A · 2019 to 2020
$424k
NIMH NIH HHS R01 MH094650NIMH NIH HHS R01 MH118741NIMH NIH HHS R21 MH103231NIMH NIH HHS R21 MH119677NIMH NIH HHS R33 MH103231NINDS NIH HHS T32 NS047987
6 · The paper itself

Abstract

Motor abnormalities (e.g., dyskinesia, psychomotor slowing, neurological soft signs) are core features of schizophrenia that occur independent of drug treatment and are associated with the genetic vulnerability and pathophysiology for the illness. Among this list, psychomotor slowing in particular is one of the most consistently observed and robust findings in the field. Critically, psychomotor slowing may serve as a uniquely promising endophenotype and/or biomarker for schizophrenia considering it is frequently observed in those with genetic vulnerability for the illness, predicts transition in subjects at high-risk for the disorder, and is associated with symptoms and recovery in patients. The purpose of the present review is to provide an overview of the history of psychomotor slowing in psychosis, discuss its possible neural underpinnings, and review the current literature supporting slowing as a putative endophenotype and/or biomarker for the illness. This review summarizes substantial evidence from a diverse array of methodologies and research designs that supports the notion that psychomotor slowing not only reflects genetic vulnerability, but is also sensitive to disease processes and the pathophysiology of the illness. Furthermore, there are unique deficits across the cognitive (prefix "psycho") and motor execution (root word "motor") aspects of slowing, with cognitive processes such as planning and response selection being particularly affected. These findings suggest that psychomotor slowing may serve as a promising endophenotype and biomarker for schizophrenia that may prove useful for identifying individuals at greatest risk and tracking the course of the illness and recovery.

Indexed as

BiomarkerCatatoniaClinical High-RiskEndophenotypePsychomotorPsychosisSchizophreniaSlowing

Identifiers

PMID33738459
PMCPMC7963400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.